These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characterization of receptors for platelet-activating factor in guinea pig lung membranes. Gomez J; Bloom JW; Yamamura HI; Halonen M Am J Respir Cell Mol Biol; 1990 Sep; 3(3):259-64. PubMed ID: 2167700 [TBL] [Abstract][Full Text] [Related]
5. Species differences in PAF receptor binding in the lungs between hamster and guinea pig. Chen J; Giris N J Lipid Mediat Cell Signal; 1997 Jun; 16(2):63-74. PubMed ID: 9172049 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation. Ring PC; Seldon PM; Barnes PJ; Giembycz MA Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515 [TBL] [Abstract][Full Text] [Related]
7. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes. Floch A; Tahraoui L; Sedivy P; Cavero I J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834 [TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor mediates the ozone-induced increase in airway microvascular leakage in guinea pigs. Kaneko T; Ikeda H; Fu L; Nishiyama H; Okubo T Eur J Pharmacol; 1995 Mar; 292(3-4):251-5. PubMed ID: 7796863 [TBL] [Abstract][Full Text] [Related]
9. Characterization of specific binding sites of 3H-labelled platelet-activating factor ([3H]PAF) and a new antagonist, [3H]SR 27417, on guinea-pig tracheal epithelial cells. Herbert JM Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):201-6. PubMed ID: 1318021 [TBL] [Abstract][Full Text] [Related]
10. Characterization of PAF receptors on human neutrophils using the specific antagonist, WEB 2086. Correlation between receptor binding and function. Dent G; Ukena D; Chanez P; Sybrecht G; Barnes P FEBS Lett; 1989 Feb; 244(2):365-8. PubMed ID: 2537761 [TBL] [Abstract][Full Text] [Related]
16. Existence of PAF receptors in human platelets and human lung tissue but not in the human myocardium. Schwinger RH; Böhm M; La Rosée K; Erdmann E Am Heart J; 1992 Aug; 124(2):320-30. PubMed ID: 1322030 [TBL] [Abstract][Full Text] [Related]
17. Platelet activating factor stimulates a receptor-coupled membrane GTPase in guinea pig eosinophils. Dent G; Barnes PJ Life Sci; 1993; 52(20):1633-40. PubMed ID: 8387140 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist. Yamada T; Saito M; Mase T; Hara H; Nagaoka H; Murase K; Tomioka K Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114 [TBL] [Abstract][Full Text] [Related]
20. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action. Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]